Spark-BIH

News

Second edition of "A Practical Guide to Drug Development in Academia: The SPARK Approach“

The second edition of "A Practical Guide to Drug Development in Academia: The SPARK Approach“ written by the founders of SPARK in SPARK Stanford Prof. Daria Mochly-Rosen and Prof. Kevin Grimes is published.

New SPARK site: SPARK the Midlands

A warm welcome to the newest member of the SPARK global community. SPARK the Midlands (Birmingham,…

SPARK-BIH welcomes 12 new projects to the program

Welcome to all new SPARK-BIH teams and a big thank you to all the 2023 Call participants

MyoPax co-founder and SPARKee professor Simone Spuler honored as UNIPRENEUR

Congratulations to Simone Spuler for being among the 20 selected outstanding individuals of 700 nominations!

NDR Podcast Episode about drug discovery of SPARKees Alessandro Prigione and Markus Schülke-Gerstenfeld

Within the new NDR Podcast episode, Prof. Schülke presented their drug discovery for mitochondrially inherited Leigh Syndrome (MILS).

ERC Consolidator Grant for SPARKee Surjo Soekadar

Prof. Surjo Soekadar awarded with two million euros for project on TIMS

SPARKee Surjo Soekadar gives talk at re:publica Berlin

Prof. Surjo Soekadar gave a captivating talk on brain-computer interfaces at re:publica Berlin

SPARK-BIH / NeuroCure Team MyaLink at BERLIN BRAINS

The NeuroCure/SPARK-supported team Myalink (Dr. Sophie Lehnerer and Dr. Maike Stein) presented their project within BERLIN BRAINS: Rare meets Care - how digital medicine opens new perspectives for rare diseases.

Our Mission

At SPARK-BIH we seek to accelerate the translation of academic inventions into clinically relevant therapies, diagnostics and medical devices by offering mentoring, funding and education.

SPARK Concept